Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net margin is calculated as Net Income divided by its Revenue. Ajooni Biotech's Net Income for the
three
months ended in Mar. 2026 was ₹0 Mil. Ajooni Biotech's Revenue for the
three
months ended in Mar. 2026 was ₹0 Mil. Therefore, Ajooni Biotech's net margin for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Ajooni Biotech's Net Margin % or its related term are showing as below:
NSE:AJOONI'
s Net Margin % Range Over the Past 10 Years
Min: 0.73 Med: 1.23 Max: 2.94
Current: 2.93
NSE:AJOONI's Net Margin % is ranked worse than 54.42% of 1957
companies
in the Consumer Packaged Goods industry
Industry Median: 3.52
vs NSE:AJOONI: 2.93
Ajooni Biotech (NSE:AJOONI) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Ajooni Biotech Net Margin % Related Terms
Ajooni Biotech Net Margin % Historical Data
* Premium members only.
The historical data trend for Ajooni Biotech's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Ajooni Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ajooni Biotech Net Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Ajooni Biotech's Net Margin % distribution charts can be found below:
* The bar in red indicates where Ajooni Biotech's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ajooni Biotech (NSE:AJOONI) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Ajooni Biotech and its competitors. Over the past decade, Ajooni Biotech's Net Margin % has ranged from 0.73 to 2.94. According to the industry distribution chart, Ajooni Biotech ranks #1065 out of 1957 companies in the Consumer Packaged Goods industry, placing it in the top 54.4%.
Is Ajooni Biotech's Net Margin % too high?
Ajooni Biotech's current Net Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 2.94. Based on the distribution chart, Ajooni Biotech ranks #1065 out of 1957 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Ajooni Biotech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ajooni Biotech's Net Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Ajooni Biotech ranks #1065 out of 1957 companies for Net Margin %. This places Ajooni Biotech in the lower half of its industry. The industry median Net Margin % is 3.52. Historically, Ajooni Biotech's own Net Margin % has ranged from 0.73 to 2.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Consumer Packaged Goods company?
The median Net Margin % among Consumer Packaged Goods companies is 3.52, based on 1,957 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Ajooni Biotech and its competitors. For the Consumer Packaged Goods industry, the median Net Margin % is 3.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ajooni Biotech's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajooni Biotech stock overvalued right now?
Based on GuruFocus' analysis, Ajooni Biotech (NSE:AJOONI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹6.26, compared to a current price of ₹3.86 — trading 38.3% below its estimated fair value. The current Net Margin % is 0.00%. Ajooni Biotech's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Ajooni Biotech (NSE:AJOONI), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ajooni Biotech (NSE:AJOONI) Overvalued in 2026?
Based on GuruFocus' analysis, Ajooni Biotech stock appears to be undervalued.
The current stock price of ₹3.86 is trading 38.3% below its estimated GF Value™ of ₹6.26.
GuruFocus considers Ajooni Biotech to be Possible Value Trap.
Key valuation signals for NSE:AJOONI:
Net Margin %: 0.00%
GF Value™: ₹6.26 vs. price of ₹3.86 (38.3% below fair value)
No single metric tells the full story. See the NSE:AJOONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
64GF Score
Get the complete analysis for NSE:AJOONI
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AJOONI has been successfully added to your 
